| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on May 24, 2004
Accepted on June 29, 2004
Diabetes Branch, NIDDK, National Institutes of Health, Bethesda, MD 20892-1758; Edison Biotechnology Institute, Ohio University College of Osteopathic Medicine, Ohio University, Athens, OH 45701, USA; Laboratory of Experimental Carcinogenesis. CCR. National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1758
* To whom correspondence should be addressed. E-mail: shoshanay{at}intra.niddk.nih.gov.
Liver regeneration is a fundamental mechanism by which the liver responds to injury. This process is regulated by endogenous growth factors and cytokines and it involves proliferation of all mature cells that exist within the intact organ. To understand the role of the growth hormone (GH)/insulin-like growth factor I (IGF-I) axis in liver regeneration, we performed partial hepatectomies in three groups of mice: GH antagonist (GHa) transgenic mice, in which the action of GH is blocked; liver IGF-I- deficient mice that lack IGF-I specifically in the liver and also lack the acid labile subunit (ALS) (LID+ALSKO mice), in which IGF-I levels are very low and GH secretion is increased; and control mice. Interestingly, the survival rate of GHa transgenic mice was dramatically reduced after partial hepatectomy (57%), compared with the survival rate of controls (100%) or LID+ALSKO mice (88%). In control mice, the liver was completely regenerated after 4 days, whereas liver regeneration required 7 days in LID+ALSKO mice. In contrast, in GHa mice liver regeneration reached only 70% of the original liver mass after 4 days and did not improve thereafter. Strikingly, at 36 and 48 h after hepatectomy, the livers of control and LID+ALSKO mice, respectively, exhibited intense BrdU-staining, whereas BrdU-staining was dramatically decreased in the livers of GHa mice. These results suggest that GH plays a critical role in liver regeneration, although whether it acts directly or indirectly remains to be determined.
This article has been cited by other articles:
![]() |
N. Masumoto, C. Tateno, A. Tachibana, R. Utoh, Y. Morikawa, T. Shimada, H. Momisako, T. Itamoto, T. Asahara, and K. Yoshizato GH enhances proliferation of human hepatocytes grafted into immunodeficient mice with damaged liver J. Endocrinol., September 1, 2007; 194(3): 529 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Conway-Campbell, J. W. Wooh, A. J. Brooks, D. Gordon, R. J. Brown, A. M. Lichanska, H. S. Chin, C. L. Barton, G. M. Boyle, P. G. Parsons, et al. Nuclear targeting of the growth hormone receptor results in dysregulation of cell proliferation and tumorigenesis PNAS, August 14, 2007; 104(33): 13331 - 13336. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-L. Wang, X. Shi, E. Salisbury, Y. Sun, J. H. Albrecht, R. G. Smith, and N. A. Timchenko Growth Hormone Corrects Proliferation and Transcription of Phosphoenolpyruvate Carboxykinase in Livers of Old Mice via Elimination of CCAAT/Enhancer-binding Protein {alpha}-Brm Complex J. Biol. Chem., January 12, 2007; 282(2): 1468 - 1478. [Abstract] [Full Text] [PDF] |
||||
![]() |
M A Hyatt, G S Gopalakrishnan, J Bispham, S Gentili, I C McMillen, S M Rhind, M T Rae, C E Kyle, A N Brooks, C Jones, et al. Maternal nutrient restriction in early pregnancy programs hepatic mRNA expression of growth-related genes and liver size in adult male sheep J. Endocrinol., January 1, 2007; 192(1): 87 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xu, Z. Liu, T. L. Clemens, and J. L. Messina Insulin Reverses Growth Hormone-induced Homologous Desensitization J. Biol. Chem., August 4, 2006; 281(31): 21594 - 21606. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pennisi, O. Gavrilova, J. Setser-Portas, W. Jou, S. Santopietro, D. Clemmons, S. Yakar, and D. LeRoith Recombinant Human Insulin-Like Growth Factor-I Treatment Inhibits Gluconeogenesis in a Transgenic Mouse Model of Type 2 Diabetes Mellitus Endocrinology, June 1, 2006; 147(6): 2619 - 2630. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Tang, R. Yu, Y. Lu, A. F. Parlow, and J.-L. Liu Age-dependent onset of liver-specific IGF-I gene deficiency and its persistence in old age: implications for postnatal growth and insulin resistance in LID mice Am J Physiol Endocrinol Metab, August 1, 2005; 289(2): E288 - E295. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |